1. Universidade Federal do Rio Grande do Norte
2. Centro de Biociências
3. DBF - Departamento de Biofísica e Farmacologia
4. CB - DBF - Artigos publicados em periódicos

Title:	Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs
Authors:	Araújo, Aurigena Antunes de Dantas, Diego de Araújo Nascimento, Gemma Galgani do Ribeiro, Susana Barbosa Chaves, Katarina Melo Silva, Vanessa de Lima Araújo Jr., Raimundo Fernandes de Souza, Dyego Leandro Bezerra de Medeiros, Caroline Addison Carvalho Xavier de
Keywords:	Schizophrenia;Atypical antipsychotic;Quality of life
Issue Date:	1-May-2014
Publisher:	Springer Science
Citation:	ARAÚJO, Aurigena Antunes de et al. Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs. Psychiatric Quarterly, p. 357-67, 2014. Disponível em: <https://link.springer.com/article/10.1007%2Fs11126-014-9290-x>. Acesso em: 19 mar. 2018.
Portuguese Abstract:	This cross-sectional study compared the effects of treatment with atypical antipsychotic drugs on quality of life (QoL) and side effects in 218 patients with schizophrenia attending the ambulatory services of psychiatric in Rio Grande do Norte, Brazil. Socio-economic variables were compared. The five-dimension EuroQoL (EQ-5D) was used to evaluate QoL, and side effects were assessed using the Udvalg for Kliniske Undersøgelser (UKU) Side Effect Rating Scale and the Simpson–Angus Scale. Data were analysed using the χ 2 test and Student’s t test, with a significance level of 5 %. Average monthly household incomes in the medication groups were 1.1–2.1 minimum wages ($339–$678). UKU Scale scores showed significant differences in side effects, mainly, clozapine, quetiapine and ziprasidone (p < 0.05). EQ-5D scores showed that all drugs except olanzapine significantly impacted mobility (p < 0.05), and proportions of individuals reporting problems in other dimensions were high: 63.6 % of clozapine users reported mobility problems, 63.7 and 56.3 % of clozapine and ziprasidone users, respectively, had difficulties with usual activities, 68.8 and 54.5 % of ziprasidone and clozapine users, respectively, experienced pain and/or discomfort, and 72.8 % of clozapine users reported anxiety and/or depression. Psychiatric, neurological, and autonomous adverse effects, as well as other side effects, were prevalent in users of atypical antipsychotic drugs, especially clozapine and ziprasidone. Olanzapine had the least side effects. QoL was impacted by side effects and economic conditions in all groups. Thus, the effects of these antipsychotic agents appear to have been masked by aggravating social and economic situations.
URI:	https://repositorio.ufrn.br/jspui/handle/123456789/25424
ISSN:	1573-6709
Appears in Collections:	CB - DBF - Artigos publicados em periódicos

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.